Coeptis Therapeutics, Inc.
COEPNASDAQHealthcare
$16.40
+$0.00(+0.00%)
Market Cap$57626976
P/E Ratio—
52W High$21.41
52W Low$6.8
Coeptis Therapeutics, Inc.（COEP）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · COEP · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.36M | $0.00M | $0.00M | $0.00M | $0.07M |
| Cost of Revenue | $0.18M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $1.18M | $0.00M | $0.00M | $0.00M | $0.07M |
| Gross Margin %(computed) | 86.75% | — | — | — | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $1.28M | $2.33M | $6.67M | $0.02M | $0.00M |
| G&A Expenses | $11.84M | $6.72M | $13.82M | $34.17M | $14.12M |
| Total Operating Expenses | $14.23M | $10.05M | $21.49M | $34.20M | $14.12M |
| Operating Income | ($13.04M) | ($10.05M) | ($21.49M) | ($34.20M) | ($14.05M) |
| Operating Margin %(computed) | -956.94% | — | — | — | — |
| Interest Income | $0.12M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.64M | $0.40M | $0.11M | $0.22M | $0.19M |
| Income Before Tax | ($12.28M) | ($10.88M) | ($21.27M) | ($37.57M) | ($13.45M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($11.92M) | ($10.68M) | ($21.27M) | ($37.57M) | ($13.45M) |
| Net Margin %(computed) | -874.29% | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-2.81 | $-5.65 | $-0.83 | $-2.87 | $-13.16 |
| Wtd Avg Shares | 4.23M | 1.93M | 25.69M | 14.30M | 1.02M |
| EBITDA | ($10.41M) | ($9.38M) | ($20.12M) | ($36.35M) | ($12.81M) |
| EBITDA Margin %(computed) | -763.89% | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Coeptis Therapeutics, Inc.
关于Coeptis Therapeutics, Inc.（COEP）损益表
Coeptis Therapeutics, Inc.（COEP）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，COEP实现营收$0.00B，毛利润$0.00B（毛利率86.75%），净利润($0.01B)（净利率-874.29%）。
常见问题
COEP · 4 问Coeptis Therapeutics, Inc.（COEP）2025财年营收为$0.00B，同比up—%。
COEP revenueCOEP salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09